Why the study?
Does surgical and interventional correction of mitral valve regurgitation provide clinical and prognostic benefit in high-risk patients?
Does surgical and interventional correction of mitral valve regurgitation provide clinical and prognostic benefit in high-risk patients?
No takes yet. Share an insight, caveat, or question.
This ESC position statement highlights the need for randomized studies to clarify the clinical and prognostic benefits of correcting mitral regurgitation in high-risk patients.
Bonis et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: